CHRISTINA HADLEY: Open Payments
NPI 1447656012 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$176 in 8 payments from 6 companies in 2025. Trend: 2023 $3,641 · 2024 $2,067 · 2025 $176
Food & beverage: $176
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $72 |
| Alkermes, Inc. | 1 | $27 |
| Collegium Pharmaceutical, Inc. | 1 | $24 |
| ABBVIE INC. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
Products named: CAPLYTA, ARISTADA, Jornay PM, VRAYLAR, Auvelity, TRINTELLIX.
Industry payments across NE — which companies pay providers there.
